Peds respiratory issues Flashcards
Asthma impairment– Ages 0-4
Symptoms less than or equal to 2 days/week
no nighttime awakenings
short-acting (SABA) is only used less than 2 days /week
No interference with normal activity
Exacerbations requiring oral systemic corticosteroids 0-1/ year
Asthma Class–Intermittent
Asthma impairment– Ages 5-11
Symptoms less than or equal to 2 days/week
nighttime awakenings less than 2 days /month
No interference with normal activity
Normal FEV1 (peak flow) between exacerbations >80%
FEV1/FVC > 85%
Exacerbations requiring oral systemic corticosteroids 0-1/ year
Asthma Class–Intermittent
Asthma impairment– Ages 0-4
Symptoms greater than to 2 days/week but not daily
nighttime awakenings 1-2 times /month
short-acting (SABA) is used more than 2 days/week but not daily
Minor limitation to normal activity
Exacerbations requiring oral systemic corticosteroids more than 2 in 6 months. More than 4 wheezing episodes/ 1 year lasting more than 1 day and risk factors for persistent asthma
Asthma Class– Mild persistent
Asthma impairment– Ages 5-11
Symptoms more than to 2 days/week but not daily
nighttime awakenings 3-4 times /month
short-acting (SABA) is used more than 2 days/week but not daily
Minor limitation to normal activity
Exacerbations requiring oral systemic corticosteroids more than 2/ year.
Asthma Class–mild persistent
Asthma impairment– Ages 0-4
Daily symptoms
nighttime awakenings 3-4 times per month
SABA used daily
Some limitation with normal activity
Asthma Class–Moderate persistent
Asthma impairment– Ages 5-11
Daily symptoms
nighttime awakenings 1 x per week but not nightly
SABA used daily
Some limitation with normal activity
Asthma Class–Moderate persistent
Asthma impairment– Ages 0-4
Throughout the day
nighttime awakenings more than 1x per week
SABA several times per day
Extremely limited activity
Asthma Class–Persistent severe
Asthma impairment– Ages 5-11
Throughout the day
nighttime awakenings often 7x per week
SABA several times per day
Extremely limited activity
Asthma Class–Persistent severe
Recommended step initiating therapy to for intermittent class
step 1 for all ages SABA PRN
Recommended step initiating therapy to for mild persistent class
Step 2–Add low-dose ICS
the alternative–cromolyn or montelukast
Consider subcutaneous allergen immunotherapy for patients who have persistent, allergic asthma
SABA as needed for symptoms.
Recommended step initiating therapy to for moderate persistent class Ages 0-4
Step 3-Medium dose ICS
and consider a short course of oral systemic corticosteroids
SABA as needed for symptoms.
Recommended step initiating therapy to for severe persistent class Ages 0-4
Step 3-Medium dose ICS
and consider a short course of oral systemic corticosteroids
SABA as needed for symptoms.
Recommended step initiating therapy to for moderate persistent class Ages 5-11
Step 3-Medium dose ICS
and consider a short course of oral systemic corticosteroids
SABA as needed for symptoms.
Recommended step initiating therapy to for severe persistent class Ages 5-11
Step 3-Medium dose ICS or Step 4- Add LABA or montekulast to ICS
and consider a short course of oral systemic corticosteroids
SABA as needed for symptoms.
If Asthma is well controlled with all ages, which are symptoms less than 2 days/ week, no more than once a day.
1 x per month of nighttime awakening
no interference with activity
SABA is only used less than 2x/week
It is well controlled–maintain the current step
regular followup every 1-6 months
consider step down if well controlled for at least 3 months.